Agreed Dicky, there are some adjustments to the norm going forward.
Two further considerations that are in the mix are : $8m usd in Aug 24 and $13m usd at end Azer-cel 1B trials monies/and or share equity payable to Precision relating to the Azer-cel acquisition. These two obligations are significant sums in either case, which will hit the cash balance or share dilution or both. If I know Paul Hopper , he will go for dilution… and on today’s share price that equates to around 550,000,000 - 550M shares for Precision. A potentially hugely valuable sum if Imugene is ultimately successful.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-59
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.7¢ |
Change
-0.002(3.13%) |
Mkt cap ! $353.3M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.6¢ | $206.1K | 4.386M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 38 | 5838327 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 1757292 | 19 |
View Market Depth
| Last trade - 13.31pm 13/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |